Scarica l'app Stockscreener
104.61
2.53%
2.58
Dopo l'orario di chiusura:
104.80
0.19
+0.18%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ILMN Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$102.03
Aprire:
$105.575
Volume 24 ore:
1.90M
Relative Volume:
0.86
Capitalizzazione di mercato:
$16.56B
Reddito:
$4.34B
Utile/perdita netta:
$-965.00M
Rapporto P/E:
-17.23
EPS:
-6.07
Flusso di cassa netto:
$869.00M
1 W Prestazione:
+7.89%
1M Prestazione:
+15.45%
6M Prestazione:
-22.37%
1 anno Prestazione:
-9.51%
Intervallo 1D:
$104.32
$105.62
Intervallo di 1 settimana:
$92.25
$105.62
Portata 52W:
$68.70
$156.66
Illumina Inc Stock (ILMN) Company Profile
Nome
Illumina Inc
Settore
Industria
Telefono
(858) 202-4500
Indirizzo
5200 ILLUMINA WAY, SAN DIEGO, CA
Confronta ILMN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
104.61 | 16.15B | 4.34B | -965.00M | 869.00M | -6.07 |
|
TMO
Thermo Fisher Scientific Inc
|
466.71 | 161.42B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
197.89 | 135.99B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
540.68 | 42.78B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
119.47 | 33.01B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
194.24 | 31.85B | 15.50B | 1.33B | 2.16B | 7.34 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-11 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | Reiterato | Citigroup | Neutral |
| 2025-02-28 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-02-10 | Downgrade | Barclays | Equal Weight → Underweight |
| 2025-02-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-11-12 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-08-28 | Aggiornamento | Argus | Hold → Buy |
| 2024-08-16 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-01-16 | Downgrade | HSBC Securities | Buy → Hold |
| 2024-01-04 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-11-10 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Iniziato | Bernstein | Underperform |
| 2023-07-05 | Ripresa | JP Morgan | Neutral |
| 2023-01-25 | Downgrade | Argus | Buy → Hold |
| 2023-01-05 | Iniziato | Scotiabank | Sector Perform |
| 2022-12-12 | Downgrade | Citigroup | Neutral → Sell |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-04 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-07-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Aggiornamento | Stifel | Hold → Buy |
| 2022-01-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Iniziato | Barclays | Underweight |
| 2020-12-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-10-13 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Downgrade | Stifel | Buy → Hold |
| 2020-09-22 | Downgrade | UBS | Buy → Neutral |
| 2020-09-21 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-09-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Downgrade | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-24 | Downgrade | Citigroup | Buy → Neutral |
| 2020-04-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Underweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-10-25 | Iniziato | Guggenheim | Buy |
Mostra tutto
Illumina Inc Borsa (ILMN) Ultime notizie
Is Illumina Inc. a good long term investmentBreakthrough stock performance - Autocar Professional
ILLUMINA, INC. (ILMN) - MSN
Whole Genome Sequencing Market Booming, to Reach US$ 8,608 - openPR.com
Multi-Omics Market Attracts Big Players, to Hit $33.25B by 2033 | - openPR.com
What analysts say about Illumina Inc. stockOutstanding growth strategies - Autocar Professional
What drives Illumina Inc. stock priceBreakneck growth rates - jammulinksnews.com
Lobbying Update: $410,000 of ILLUMINA INC. lobbying was just disclosed - Quiver Quantitative
DNA Test Kits Market Booming with Consumer Genomics Demand - openPR.com
Bioinformatics Services Market Surge Backed by Genomics - openPR.com
Illumina Inc. Stock Analysis and ForecastUnstoppable profit momentum - jammulinksnews.com
Illumina India Wins the Top GCC Award at the 2025 GCC Workplace Awards - ThePrint
Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025 - GlobeNewswire Inc.
Published on: 2025-07-19 09:23:06 - jammulinksnews.com
Killer acquisitions: what the future holds post-Illumina — Consumer Competition Market Blog - Faculteit Rechtsgeleerdheid en Criminologische Wetenschappen
Favorable Government Support Fuels Germany's Biotech Innovation and Commercialization: Market to Surpass USD 94 Billion by 2034 Led by QIAGEN, Thermo Fisher Scientific, Illumina and Roche - Yahoo Finance
Illumina’s SWOT analysis: genomics giant faces headwinds as stock outlook shifts - Investing.com
March 2026 Options Now Available For Illumina (ILMN) - Nasdaq
Illumina Stock: What Went Wrong And Why It's Best To Stay Away - 富途牛牛
Single-Cell Omics Market Growth in Future Scope 2025-2032 |10x - openPR.com
DNA Microarray Market Size, Industry Growth Insights Report - openPR.com
Bioinformatics Market Set to Witness Significant Growth by 2033 - openPR.com
How To Trade (ILMN) - news.stocktradersdaily.com
Illumina: Higher Profit Margin Despite GRAIL Divestiture And Macroeconomic Headwinds - Seeking Alpha
Illumina stock downgraded at Scotiabank (ILMN:NASDAQ) - Seeking Alpha
Scotiabank Downgrades Illumina to Sector Perform From Sector Outperform, Reduces Price Target to $125 From $164 - MarketScreener
Illumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025 - 富途牛牛
Industry Focus eBook: Infectious diseases - News-Medical
Illumina named to TIME's World's Most Sustainable Companies list for the second consecutive year - PR Newswire
Illumina Achieves Double Recognition: #2 Most Sustainable US Company and Best Workplace Excellence - Stock Titan
Illumina, Inc.'s (NASDAQ:ILMN) Shareholders Might Be Looking For Exit - simplywall.st
Illumina Shares Fall After Citigroup Downgrade - MarketScreener
Why Illumina (ILMN) Shares Are Falling Today - Yahoo Finance
Illumina: Citigroup downgrades to 'Sell' Rating, The Target Price is $80 - AInvest
Illumina stock down as Citi cuts on recent rally (ILMN:NASDAQ) - Seeking Alpha
Illumina Shares Slip After Citi Issues Bearish Rating Ahead of Earnings - MSN
Illumina Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛
Illumina Inc Azioni (ILMN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.84%
1.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):